This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

       

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Request a contact

Stay informed

Request a Rep

Nucala

Once-monthly dosing 1

Nucala is the only once-monthly* asthma biologic with a single fixed dose.

POSOLOGY

Back

Nucala is the only once-monthly* asthma biologic with a single first dose. 1

Find out full posology information for Nucala.
See the SmPC

STORAGE AND DISPOSAL 1

Back

The shelf-life of Nucala 100mg powder is 4 years.

Lyophilised powder

The reconstituted solution, if not used immediately, must be:

  • Store below 25◦ C
  • Do not freeze
  • Keep the vial in the outer carton in order to protect from light

Chemical and physical stability of the reconstituted medicinal product have been demonstrated for 8 hours when stored below 30◦ C.

From a microbiological point of view, unless the method of reconstitution precludes the risk of microbial contamination, the product should be used immediately. If not used immediately, in-use storage times and conditions are the responsibility of the user.

Disposal 1
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

Access more information on the storage and disposal of Nucala.
See the SmPC

SC, subcutaneous; SEA, severe eosinophilic asthma

*Every 4 weeks 1

References:

  1. Local Nucala Prescribing Information based on GDS 12.

Nucala is registered trademark of the GlaxoSmithKline Group of Companies

Nucala is generally well tolerated. In clinical trials, Nucala had a similar incidence of adverse events vs. placebo with the exception of injection site reactions (8% vs. 3%), which occurred mainly within first 3 injections. 1